New drug could boost survival after cardiac arrest by calming Body's overreaction
NCT ID NCT07176754
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether giving a drug that blocks a key inflammatory protein (TNF-alpha) within 6 hours after a cardiac arrest can help more people survive. The trial includes 208 adults who remain unconscious after their heartbeat is restored. The goal is to see if the drug improves survival at 30 days and reduces long-term brain damage.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIAC ARREST (CA) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Peking University Third Hospital
Beijing, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can targeted temperature control boost brain recovery after cardiac arrest?
- Blood test may forecast brain recovery after cardiac arrest
- Can a High-Tech CPR bundle boost heart restart rates?
- Could chilling the body after cardiac arrest save more brains?
- A simple bedside test may predict brain damage after cardiac arrest
- Can a neck patch spot a heartbeat faster than a Doctor's fingers?